San Francisco General Hospital
12
1
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 55/100
16.7%
2 terminated/withdrawn out of 12 trials
81.8%
-4.7% vs industry average
33%
4 trials in Phase 3/4
44%
4 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Statins In Intracerbral Hemorrhage
Role: collaborator
Chronic Hypertension and Pregnancy (CHAP) Project
Role: collaborator
Effects of COVID-19 Convalescent Plasma (CCP) on Coronavirus-associated Complications in Hospitalized Patients
Role: collaborator
Cardiac Recovery Through Dietary Support
Role: collaborator
Diabetes Prevention Among Post-partum Women With History of Gestational Diabetes
Role: collaborator
Bococizumab HIV Evaluation (B-HIVE) Study
Role: collaborator
Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Role: collaborator
Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma Patients
Role: collaborator
Is Fructose Linked to Adiposity in Babies?
Role: collaborator
Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation
Role: collaborator
Cholesterol and Pharmacogenetic Study
Role: collaborator
Calcium and Lipid Metabolism
Role: collaborator
All 12 trials loaded